Skip to content
lsd.com
CompletedNot applicable

Esketamine on Postpartum Depression in Cesarean Section Women

NCT04860661 · EKET · Ailin Luo

Closed to entry
Status
Not accepting participants
Not applicable
Phase
336
Target enrolment
1
Study sites
Outside the US

What it is testing

Summary

This study was to explore the preventive effect of esketamine on postpartum depression (PPD) in cesarean section, and to evaluate the safety of the drug

Summary as written by the trial’s own sponsor and published on ClinicalTrials.gov API v2. It is the sponsor’s description, reproduced unedited, not an assessment by this site.

What counts as success

Primary outcome measures

  • Edinburgh Postnatal Depression Scale(EPDS） scores

    Measured over up to 90 days after surgery

A trial succeeds or fails on its primary outcome, declared in advance. Everything else it reports is secondary by definition.

Who can take part

Eligibility, as published

18 Years to 40 Years
Ages
FEMALE
Sex
Not accepted
Healthy volunteers
Inclusion Criteria: * Elective cesarean section; * 18-40 years; * Primipara; * Singleton pregnancy; * Sign informed consent. Exclusion Criteria: * American Society of Anesthesiologists (ASA) grade III and above; * Intracranial hypertension; * Hypertension; * Severe heart disease; * Hyperthyroidism patients without treatment or insufficient treatment; * Liver and kidney dysfunction; * Preeclampsia or eclampsia; * Mental disorder, mental retardation; * Drug abuse and alcoholism; * Contraindication of intraspinal anesthesia; * The preoperative EPDS score ≥10; * Participated in other clinical studies.

Where

1 study site

FacilityCityRegionCountry
Tongji HospitalWuhanHubeiChina

On the registry

Contact the trial directly

This site does not enrol anyone and is not involved in this trial. To ask about taking part, use the sponsor’s own contact details on the official registry record, which is also where the most current version of everything above lives.

Before you do, the preparation checklist lists what a site will ask you on a first call and what is worth asking them. It is free and collects nothing.

NCT04860661 on ClinicalTrials.gov →

Last updated in the registry 2024-08-06. Registry records change; this page reflects the data build of 2026-08-25.

Related

Where this trial sits

Substance